America's pharmaceutical research and biotechnology companies are developing 34 medicines for diseases that disproportionally affect American women. The new report, Medicines in Development for Women, is presented by the Pharmaceutical Research and Manufacturers of America in cooperation with Prevent Blindness America and other national health organizations.
In addition to glaucoma and dry eye medicines in development, the report lists 155 medicines in development for diabetes, also a major cause of vision loss for women.
Treatment of age-related eye diseases, including glaucoma and diabetic eye disease, costs $51.4 billion annually.
For the full report, please visit www.phrma.org.
Founded in 1908, Prevent Blindness America is the nation's leading patient and consumer advocate dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness America touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, divisions and chapters, it's committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020.
|
